3/4
08:00 am
slno
Soleno Therapeutics (SLNO) had its price target lowered by HC Wainwright from $120.00 to $100.00. They now have a "buy" rating on the stock.
Low
Report
Soleno Therapeutics (SLNO) had its price target lowered by HC Wainwright from $120.00 to $100.00. They now have a "buy" rating on the stock.
3/4
02:44 am
slno
Soleno Therapeutics, Inc. (SLNO) Revenue Tops Expectations With $91.7M in Q4 Results, TD Cowen Maintains Buy [Yahoo! Finance]
Low
Report
Soleno Therapeutics, Inc. (SLNO) Revenue Tops Expectations With $91.7M in Q4 Results, TD Cowen Maintains Buy [Yahoo! Finance]
3/1
04:40 am
slno
Wells Fargo Cuts PT on Soleno Therapeutics (SLNO) to $110 From $114 – Here's Why [Yahoo! Finance]
Medium
Report
Wells Fargo Cuts PT on Soleno Therapeutics (SLNO) to $110 From $114 – Here's Why [Yahoo! Finance]
2/28
03:15 am
slno
Soleno Profitability Milestone And CFO Shift Raise Valuation Questions [Yahoo! Finance]
Medium
Report
Soleno Profitability Milestone And CFO Shift Raise Valuation Questions [Yahoo! Finance]
2/27
07:48 pm
slno
Soleno Therapeutics, Inc. Q4 2025 Earnings Call Summary [Yahoo! Finance]
Medium
Report
Soleno Therapeutics, Inc. Q4 2025 Earnings Call Summary [Yahoo! Finance]
2/27
11:41 am
slno
Soleno Therapeutics (SLNO) had its price target lowered by Wells Fargo & Company from $114.00 to $110.00. They now have an "overweight" rating on the stock.
Low
Report
Soleno Therapeutics (SLNO) had its price target lowered by Wells Fargo & Company from $114.00 to $110.00. They now have an "overweight" rating on the stock.
2/26
01:36 pm
slno
Soleno Therapeutics (SLNO) had its price target lowered by TD Cowen from $120.00 to $85.00. They now have a "buy" rating on the stock.
Medium
Report
Soleno Therapeutics (SLNO) had its price target lowered by TD Cowen from $120.00 to $85.00. They now have a "buy" rating on the stock.
2/26
08:34 am
slno
Soleno Therapeutics Announces Retirement of James Mackaness and Appointment of Jennifer Fulk as Chief Financial Officer [Yahoo! Finance]
Medium
Report
Soleno Therapeutics Announces Retirement of James Mackaness and Appointment of Jennifer Fulk as Chief Financial Officer [Yahoo! Finance]
2/26
08:00 am
slno
Soleno Therapeutics Announces Retirement of James Mackaness and Appointment of Jennifer Fulk as Chief Financial Officer
Medium
Report
Soleno Therapeutics Announces Retirement of James Mackaness and Appointment of Jennifer Fulk as Chief Financial Officer
2/26
03:27 am
slno
Soleno Therapeutics Q4 Earnings Call Highlights [Yahoo! Finance]
Medium
Report
Soleno Therapeutics Q4 Earnings Call Highlights [Yahoo! Finance]
2/25
06:31 pm
slno
Soleno (SLNO) Q4 2025 Earnings Call Transcript [Yahoo! Finance]
Medium
Report
Soleno (SLNO) Q4 2025 Earnings Call Transcript [Yahoo! Finance]
2/25
04:01 pm
slno
Soleno Therapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides Update on U.S. Launch of VYKAT™ XR
Medium
Report
Soleno Therapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides Update on U.S. Launch of VYKAT™ XR
2/16
12:38 pm
slno
Soleno Therapeutics (SLNO) Sparks Confidence Amid Topline Outperformance [Yahoo! Finance]
Low
Report
Soleno Therapeutics (SLNO) Sparks Confidence Amid Topline Outperformance [Yahoo! Finance]
2/11
08:12 am
slno
Soleno Therapeutics to Report Fourth Quarter and Full-Year 2025 Financial Results on February 25, 2026, at 4:30 PM ET [Yahoo! Finance]
Low
Report
Soleno Therapeutics to Report Fourth Quarter and Full-Year 2025 Financial Results on February 25, 2026, at 4:30 PM ET [Yahoo! Finance]
2/11
08:00 am
slno
Soleno Therapeutics to Report Fourth Quarter and Full-Year 2025 Financial Results on February 25, 2026, at 4:30 PM ET
Low
Report
Soleno Therapeutics to Report Fourth Quarter and Full-Year 2025 Financial Results on February 25, 2026, at 4:30 PM ET
2/5
06:10 am
slno
Soleno Therapeutics (NASDAQ:SLNO) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
Medium
Report
Soleno Therapeutics (NASDAQ:SLNO) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
2/2
11:34 am
slno
Down 18.3% in 4 Weeks, Here's Why Soleno Therapeutics (SLNO) Looks Ripe for a Turnaround [Yahoo! Finance]
Low
Report
Down 18.3% in 4 Weeks, Here's Why Soleno Therapeutics (SLNO) Looks Ripe for a Turnaround [Yahoo! Finance]
1/29
08:17 am
slno
Soleno Therapeutics to Participate in Upcoming Conferences [Yahoo! Finance]
Medium
Report
Soleno Therapeutics to Participate in Upcoming Conferences [Yahoo! Finance]
1/29
08:00 am
slno
Soleno Therapeutics to Participate in Upcoming Conferences
Low
Report
Soleno Therapeutics to Participate in Upcoming Conferences
1/24
05:10 am
slno
Soleno Therapeutics (NASDAQ:SLNO) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Soleno Therapeutics (NASDAQ:SLNO) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
1/24
03:17 am
slno
Soleno Therapeutics Inc. (SLNO): Analysts See Major Upside [Yahoo! Finance]
Low
Report
Soleno Therapeutics Inc. (SLNO): Analysts See Major Upside [Yahoo! Finance]
1/23
07:09 pm
slno
Is Soleno Therapeutics, Inc. (NASDAQ:SLNO) The Best Under $50 Stock to Buy Now? [Yahoo! Finance]
Low
Report
Is Soleno Therapeutics, Inc. (NASDAQ:SLNO) The Best Under $50 Stock to Buy Now? [Yahoo! Finance]
1/20
09:27 am
slno
Johnson Fistel Begins Investigation on Behalf of Soleno Therapeutics, Inc. (SLNO) Shareholders Who Have Incurred Losses
Low
Report
Johnson Fistel Begins Investigation on Behalf of Soleno Therapeutics, Inc. (SLNO) Shareholders Who Have Incurred Losses
1/20
08:02 am
slno
Soleno Therapeutics (NASDAQ:SLNO) had its "overweight" rating reaffirmed by analysts at Wells Fargo & Company.
Medium
Report
Soleno Therapeutics (NASDAQ:SLNO) had its "overweight" rating reaffirmed by analysts at Wells Fargo & Company.
1/20
07:17 am
slno
Soleno Therapeutics (NASDAQ:SLNO) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Medium
Report
Soleno Therapeutics (NASDAQ:SLNO) had its "buy" rating reaffirmed by analysts at HC Wainwright.